An Adaptable Standard for Protein Export from the Endoplasmic Reticulum

To provide an integrated view of endoplasmic reticulum (ER) function in protein export, we have described the interdependence of protein folding energetics and the adaptable biology of cellular protein folding and transport through the exocytic pathway. A simplified treatment of the protein homeostasis network and a formalism for how this network of competing pathways interprets protein folding kinetics and thermodynamics provides a framework for understanding cellular protein trafficking. We illustrate how folding and misfolding energetics, in concert with the adjustable biological capacities of the folding, degradation, and export pathways, collectively dictate an adaptable standard for protein export from the ER. A model of folding for export (FoldEx) establishes that no single feature dictates folding and transport efficiency. Instead, a network view provides insight into the basis for cellular diversity, disease origins, and protein homeostasis, and predicts strategies for restoring protein homeostasis in protein-misfolding diseases.

[1]  D. Perlmutter,et al.  Pathogenesis of Chronic Liver Injury and Hepatocellular Carcinoma in Alpha-1-Antitrypsin Deficiency , 2006, Pediatric Research.

[2]  John D. Venable,et al.  Hsp90 Cochaperone Aha1 Downregulation Rescues Misfolding of CFTR in Cystic Fibrosis , 2006, Cell.

[3]  J. Asenjo,et al.  Kinetic model of BiP- and PDI-mediated protein folding and assembly. , 2002, Journal of theoretical biology.

[4]  H. Katinger,et al.  Effect of Increased Expression of Protein Disulfide Isomerase and Heavy Chain Binding Protein on Antibody Secretion in a Recombinant CHO Cell Line , 2008, Biotechnology progress.

[5]  L. Hendershot,et al.  Organization of the functions and components of the endoplasmic reticulum. , 2007, Advances in experimental medicine and biology.

[6]  I. Wada,et al.  EDEM As an Acceptor of Terminally Misfolded Glycoproteins Released from Calnexin , 2003, Science.

[7]  D. Clarke,et al.  Chemical and pharmacological chaperones as new therapeutic agents , 2007, Expert Reviews in Molecular Medicine.

[8]  J. Kelly,et al.  Therapeutic strategies to ameliorate lysosomal storage disorders – a focus on Gaucher disease , 2006, Cellular and Molecular Life Sciences CMLS.

[9]  J. Riordan,et al.  Assembly of functional CFTR chloride channels. , 2005, Annual review of physiology.

[10]  Fred E. Cohen,et al.  Therapeutic approaches to protein-misfolding diseases , 2003, Nature.

[11]  R. Kaufman,et al.  Derlin-2 and Derlin-3 are regulated by the mammalian unfolded protein response and are required for ER-associated degradation , 2006, The Journal of cell biology.

[12]  M. Katze,et al.  Cotranslocational Degradation Protects the Stressed Endoplasmic Reticulum from Protein Overload , 2006, Cell.

[13]  K. Wittrup,et al.  Contrasting secretory processing of simultaneously expressed heterologous proteins in Saccharomyces cerevisiae , 2006, Biotechnology and bioengineering.

[14]  D. Thirumalai,et al.  Thermal denaturation and folding rates of single domain proteins: size matters , 2003, q-bio/0310020.

[15]  S. Lindquist,et al.  Hsp90 as a capacitor of phenotypic variation , 2002, Nature.

[16]  S. Stagg,et al.  The COPII cage: unifying principles of vesicle coat assembly , 2006, Nature Reviews Molecular Cell Biology.

[17]  E. Yilmaz,et al.  Chemical Chaperones Reduce ER Stress and Restore Glucose Homeostasis in a Mouse Model of Type 2 Diabetes , 2006, Science.

[18]  P. Wolynes,et al.  The experimental survey of protein-folding energy landscapes , 2005, Quarterly Reviews of Biophysics.

[19]  K D Wittrup,et al.  Secretion efficiency in Saccharomyces cerevisiae of bovine pancreatic trypsin inhibitor mutants lacking disulfide bonds is correlated with thermodynamic stability. , 1998, Biochemistry.

[20]  Jason C. Young,et al.  Pathways of chaperone-mediated protein folding in the cytosol , 2004, Nature Reviews Molecular Cell Biology.

[21]  F. Doyle,et al.  Analysis of unfolded protein response during single-chain antibody expression in Saccaromyces cerevisiae reveals different roles for BiP and PDI in folding. , 2005, Metabolic engineering.

[22]  Jonathan Weissman,et al.  Molecular Chaperones and Protein Quality Control , 2006, Cell.

[23]  C. Dobson,et al.  Impact of the native‐state stability of human lysozyme variants on protein secretion by Pichia pastoris , 2006, The FEBS journal.

[24]  Richard I. Morimoto,et al.  Progressive Disruption of Cellular Protein Folding in Models of Polyglutamine Diseases , 2006, Science.

[25]  John D. Venable,et al.  Metalloendoprotease cleavage triggers gelsolin amyloidogenesis , 2005, The EMBO journal.

[26]  P. Walter,et al.  Signal integration in the endoplasmic reticulum unfolded protein response , 2007, Nature Reviews Molecular Cell Biology.

[27]  W. Guggino,et al.  New insights into cystic fibrosis: molecular switches that regulate CFTR , 2006 .

[28]  Theodore R Rieger,et al.  Bistability explains threshold phenomena in protein aggregation both in vitro and in vivo. , 2006, Biophysical journal.

[29]  M. Aridor.  Visiting the ER: the endoplasmic reticulum as a target for therapeutics in traffic related diseases. , 2007, Advanced drug delivery reviews.

[30]  J. Brodsky.  The protective and destructive roles played by molecular chaperones during ERAD (endoplasmic-reticulum-associated degradation). , 2007, The Biochemical journal.

[31]  D. Lauffenburger,et al.  Model for ER chaperone dynamics and secretory protein interactions , 1996 .

[32]  J. Kelly,et al.  The Biological and Chemical Basis for Tissue-Selective Amyloid Disease , 2005, Cell.

[33]  I. Wada,et al.  A novel ER α‐mannosidase‐like protein accelerates ER‐associated degradation , 2001 .

[34]  A. Fersht.  Structure and mechanism in protein science , 1998 .

[35]  A. Helenius,et al.  Roles of N-linked glycans in the endoplasmic reticulum. , 2004, Annual review of biochemistry.